Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis

OncoImmunology

Volumn 6, Issue 2, 2017, Pages

  Ortner, Daniela ^a   Tripp, Christoph H ^a   Komenda, Kerstin ^a   Dubrac, Sandrine ^a   Zelger, Bernhard ^a   Hermann, Martin ^a   Doppler, Wolfgang ^a   Tymoszuk, Piotr Z ^a   Boon, Louis ^b   Clausen, Björn E ^c   Stoitzner, Patrizia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Biocerus   (Netherlands)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Chemical carcinogenesis; epidermis; immunosurveillance; Langerhans cells; NK cells

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTONE H2AX; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 7 RECEPTOR; LANGERIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2D; PEPTIDES AND PROTEINS; PHORBOL 13 ACETATE 12 MYRISTATE; RIBONUCLEIC ACID EXPORT 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOFLUORESCENCE; LANGERHANS CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; TUMOR GROWTH;

EID: 85011271278     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1260215     Document Type: Article

References (52)

1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-83; PMID:11274625; http://dx.doi.org/10.1056/NEJM200103293441306
2. Yuspa SH. The pathogenesis of squamous cell cancer:lessons learned from studies of skin carcinogenesis. J Dermatol Sci 1998; 17:1-7; PMID:9651822; http://dx.doi.org/10.1016/S0923-1811(97)00071-6
3. Rundhaug JE, Fischer SM. Molecular mechanisms of mouse skin tumor promotion. Cancers 2010; 2:436-82; PMID:21297902; http://dx.doi.org/10.3390/cancers2020436
4. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12:721-7; PMID:10894171; http://dx.doi.org/10.1016/S1074-7613(00)80222-8
5. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system:role of natural killer cell receptors. Nat Rev Immunol 2009; 9:568-80; PMID:19629084; http://dx.doi.org/10.1038/nri2604
6. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001; 413:165-71; PMID:11557981; http://dx.doi.org/10.1038/35093109
7. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9; PMID:11567106; http://dx.doi.org/10.1126/science.1063916
8. Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008; 9:146-54; PMID:18176566; http://dx.doi.org/10.1038/ni1556
9. Antsiferova M, Huber M, Meyer M, Piwko-Czuchra A, Ramadan T, MacLeod AS, Havran WL, Dummer R, Hohl D, Werner S. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nat Commun 2011; 2:576; PMID:22146395; http://dx.doi.org/10.1038/ncomms1585
10. Steinman RM. Decisions about dendritic cells:past, present, and future. Ann Rev Immunol 2012; 30:1-22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839
11. Clausen BE, Stoitzner P. Functional specialization of skin dendritic cell subsets in regulating T cell responses. Front Immunol 2015; 6:534; PMID:26557117; http://dx.doi.org/10.3389/fimmu.2015.00534
12. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005; 23:611-20; PMID:16356859; http://dx.doi.org/10.1016/j.immuni.2005.10.008
13. Modi BG, Neustadter J, Binda E, Lewis J, Filler RB, Roberts SJ, Kwong BY, Reddy S, Overton JD, Galan A, et al. Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 2012; 335:104-8; PMID:22223807; http://dx.doi.org/10.1126/science.1211600
14. Lewis JM, Burgler CD, Fraser JA, Liao H, Golubets K, Kucher CL, Zhao PY, Filler RB, Tigelaar RE, Girardi M. Mechanisms of chemical cooperative carcinogenesis by epidermal langerhans cells. J Invest Dermatol 2015; 135:1405-14; PMID:25233073; http://dx.doi.org/10.1038/jid.2014.411
15. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006; 7:517-23; PMID:16565719; http://dx.doi.org/10.1038/ni1322
16. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169:569-76; PMID:15897263; http://dx.doi.org/10.1083/jcb.200501071
17. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 2010; 130:2752-9; PMID:20703247; http://dx.doi.org/10.1038/jid.2010.223
18. Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 2004; 25:1771-8; PMID:15105299; http://dx.doi.org/10.1093/carcin/bgh170
19. Yusuf N, Timares L, Seibert MD, Xu H, Elmets CA. Acquired and innate immunity to polyaromatic hydrocarbons. Toxicol Appl Pharmacol 2007; 224:308-12; PMID:17258781; http://dx.doi.org/10.1016/j.taap.2006.12.009
20. Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther 2003; 2:233-5; PMID:12878854; http://dx.doi.org/10.4161/cbt.2.3.373
21. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells:“l'union fait la force.” Blood 2005; 106:2252-8; PMID:15933055; http://dx.doi.org/10.1182/blood-2005-03-1154
22. Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014; 41:354-65; PMID:25238093; http://dx.doi.org/10.1016/j.immuni.2014.09.005
23. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Dendritic cells directly trigger NK cell functions:cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999; 5:405-11; PMID:10202929; http://dx.doi.org/10.1038/7403
24. Xu J, Chakrabarti AK, Tan JL, Ge L, Gambotto A, Vujanovic NL. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood 2007; 109:3333-41; PMID:17164346; http://dx.doi.org/10.1182/blood-2006-06-026385
25. Ferlazzo G, Morandi B. Cross-talks between natural killer cells and distinct subsets of dendritic cells. Front Immunol 2014; 5:159; PMID:24782864; http://dx.doi.org/10.3389/fimmu.2014.00159
26. Kemp CJ. Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin Cancer Biol 2005; 15:460-73; PMID:16039870; http://dx.doi.org/10.1016/j.semcancer.2005.06.003
27. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436:1186-90; PMID:15995699; http://dx.doi.org/10.1038/nature03884
28. Cipolat S, Hoste E, Natsuga K, Quist SR, Watt FM. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. eLife 2014; 3:e01888; PMID:24843010; http://dx.doi.org/10.7554/eLife.01888
29. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor:expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1:119-26; PMID:11248803; http://dx.doi.org/10.1038/77793
30. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98:11521-6; PMID:11562472; http://dx.doi.org/10.1073/pnas.201238598
31. Girardi M, Glusac E, Filler RB, Roberts SJ, Propperova I, Lewis J, Tigelaar RE, Hayday AC. The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J Exp Med 2003; 198:747-55; PMID:12953094; http://dx.doi.org/10.1084/jem.20021282
32. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176:1517-24; PMID:16424180; http://dx.doi.org/10.4049/jimmunol.176.3.1517
33. Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat immunol 2009; 10:75-82; PMID:19029904; http://dx.doi.org/10.1038/ni.1681
34. Buentke E, Heffler LC, Wilson JL, Wallin RP, Lofman C, Chambers BJ, Ljunggren HG, Scheynius A. Natural killer and dendritic cell contact in lesional atopic dermatitis skin–Malassezia-influenced cell interaction. J Invest Dermatol 2002; 119:850-7; PMID:12406330; http://dx.doi.org/10.1046/j.1523-1747.2002.00132.x
35. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16(−) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36:118-28; PMID:16323244; http://dx.doi.org/10.1002/eji.200535243
36. Carbone T, Nasorri F, Pennino D, Eyerich K, Foerster S, Cifaldi L, Traidl-Hoffman C, Behrendt H, Cavani A. CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol 2010; 184:1102-10; PMID:20008290; http://dx.doi.org/10.4049/jimmunol.0902518
37. Smyth MJ, Crowe NY, Godfrey DI. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol 2001; 13:459-63; PMID:11282985; http://dx.doi.org/10.1093/intimm/13.4.459
38. Swanson HI. Cytochrome P450 expression in human keratinocytes:an aryl hydrocarbon receptor perspective. Chem Biol Interact 2004; 149:69-79; PMID:15501429; http://dx.doi.org/10.1016/j.cbi.2004.08.006
39. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more:langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234:120-41; PMID:20193016; http://dx.doi.org/10.1111/j.0105-2896.2009.00886.x
40. Bennett CL, Clausen BE. DC ablation in mice:promises, pitfalls, and challenges. Trends Immunol 2007; 28:525-31; PMID:17964853; http://dx.doi.org/10.1016/j.it.2007.08.011
41. Munz C, Dao T, Ferlazzo G, de Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 2005; 105:266-73; PMID:15331446; http://dx.doi.org/10.1182/blood-2004-06-2492
42. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996; 26:659-68; PMID:8605935; http://dx.doi.org/10.1002/eji.1830260323
43. Stoll S, Jonuleit H, Schmitt E, Muller G, Yamauchi H, Kurimoto M, Knop J, Enk AH. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC):DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998; 28:3231-9; PMID:9808192; http://dx.doi.org/10.1002/(SICI)1521-4141(199810)28:10%3c3231::AID-IMMU3231%3e3.0.CO;2-Q
44. Romano E, Cotari JW, Barreira da Silva R, Betts BC, Chung DJ, Avogadri F, Fink MJ, St Angelo ET, Mehrara B, Heller G, et al. Human Langerhans cells use an IL-15R-alpha/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1. Blood 2012; 119:5182-90; PMID:22510877; http://dx.doi.org/10.1182/blood-2011-09-382200
45. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003; 4:175-81; PMID:12496964; http://dx.doi.org/10.1038/ni880
46. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Münz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004; 101:16606-11; PMID:15536127; http://dx.doi.org/10.1073/pnas.0407522101
47. Makarenkova V, Chakrabarti AK, Liberatore JA, Popovic P, Lu G, Watkins S, Vujanovic NL. Dendritic cells and natural killer cells interact via multiple TNF family molecules. J Leukoc Biol 2005; 77:408-13; PMID:15604121; http://dx.doi.org/10.1189/jlb.1104675
48. Larrick JW, Morhenn V, Chiang YL, Shi T. Activated Langerhans cells release tumor necrosis factor. J Leukoc Biol 1989; 45:429-33; PMID:2708913.
49. Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller C, Stingl G. Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 1992; 149:3524-34; PMID:1431123
50. Smyth MJ, Kelly JM, Baxter AG, Korner H, Sedgwick JD. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med 1998; 188:1611-9; PMID:9802973; http://dx.doi.org/10.1084/jem.188.9.1611
51. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, Girolomoni G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005; 174:5047-56; PMID:15814736; http://dx.doi.org/10.4049/jimmunol.174.8.5047
52. Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med 2013; 210:2057-69; PMID:24043758; http://dx.doi.org/10.1084/jem.20130783